Kelly Garvin, BSN, RN, OCN, discussed methods to communicate the benefits and risks of CAR T-cell therapy to patients and recognize AEs.
Lindsay Fischer
Advertisement
Articles by Lindsay Fischer
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Intellia Puts Phase 3 Trials for Transthyretin Amyloidosis Gene Editing Therapy Nex-Z on Hold Following Grade 4 Liver AE
2
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
3
Guess the Therapy Answer October 29, 2025
4
Quarter Century Update: The Continued Unknowns of Cell and Gene Therapy
5
